drugset / Trial / NCT04798469

Pain Alleviation With Testosterone in Opioid-Induced Hypogonadism

NCT04798469

Phase 2 Recruiting 150 enrolled Brigham and Women's Hospital
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The aim of this trial is to evaluate whether testosterone replacement results in greater improvement in pain perception, pain tolerance, sexual function, fatigue, and quality of life when compared with placebo in men with chronic spinal pain treated with opioids who have opioid-induced hypogonadism (low testosterone).

Timeline

Start
2022-01-10
Primary completion
2027-09-30
Completion
2027-12-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Testosterone Undecanoate Small molecule 750 mg Intramuscular